评估Hemay808不同浓度给药方案用于轻中度特应性皮炎患者的多中心、随机、盲法、赋形剂平行对照的Ⅱ期临床研究
本研究的主要目的是与赋形剂相比,探索不同浓度给药方案的Hemay808用于轻中度特应性皮炎的疗效及剂量效应关系。
Assess Hemay808 Concentration of Different Dosage Regimen for Mild and Moderate Atopic Dermatitis Patients the Safety and Efficacy of Multicenter, Randomized, Blinded, Excipient Parallel-group Phase Ⅱ Clinical Study
Assess Hemay808 concentration of 1%/3%/7% for treatment of mild and moderate adult atopic dermatitis patients.
A Phase I Clinical Study Assessed the Safety Tolerance and Pharmacokinetic Characteristics of Hemay808 in Healthy Adult Volunteers
This is a first-in-human study in health volunteers. The purpose is the local tolerability and systemic safety of Hemay808, which is an ointment made of a novel small molecule Hemay028. The safety and systemic pharmacokinetics (PK) of Hemay028 will be evaluated following topical application of Hemay808 to healthy volunteers.
100 项与 Hemay808 相关的专利(医药)